Find the latest Applied Therapeutics, Inc. (APLT) stock quote, history, news and other vital information to help you with your stock trading and investing.

- Company completed Late-Cycle review meeting with FDA - FDA no longer intends to hold Advisory Committee meeting - FDA Review of NDA continues to proceed as ...

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia. NEW YORK, Nov. 27, ...

Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow. The pharma company's shares are getting crushed after regulators decline to green ...

2 дня назад · Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after the U.S. health ...

2 дня назад · The FDA last week denied approval for Applied Therapeutics' investigational aldose reductase inhibitor govorestat for the treatment of classic ...

8 часов назад · In rejecting govorestat for galactosemia, the FDA cited deficiencies in Applied Therapeutics' drug application. The company plans to engage the ...

Today's Range: 1.68 - 2.09. 52 Week Range ... Latest News. category · Applied Therapeutics says it received FDA's warning letter for genetic disease drug study.

Latest APLT News · Stocks. Applied Therapeutics (APLT) Stock Plunges 75% as FDA Rules Against Genetic Drug · Stocks. Biotech Stock Roundup: BBIO Stock Up on Drug ...

Get Applied Therapeutics Inc (APLT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.